ENANTA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 827 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 551-575 of 826 matching filings.

Per page
25
Current page
23
SC 13G/A File 005-87373

SC 13G/A filing

Filing date
12 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35839

DEFA14A

Filing date
06 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35839

DEF 14A

Filing date
06 Jan 2017
Reporting date
16 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-35839

FORM 10-K/A

Filing date
06 Jan 2017
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
06 Jan 2017
Reporting date
06 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2017
Reporting date
04 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-215011

S-8

Filing date
09 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A filing

Filing date
09 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Nov 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
20 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
20 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
26 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
22 Nov 2016
Reporting date
18 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
21 Nov 2016
Reporting date
21 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Sep 2016
Reporting date
28 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Sep 2016
Reporting date
28 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .